Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions.

Pathology international - 1 Dec 2021

Hu Yanjiao, Li Guangqi, Wang Lili, Zhang Longxiao, Guan Jingjing, Wang Jigang

Abstract excerpt

The genetic alterations in the recurrent breast fibroepithelial tumors are poorly understood. In the present study, we aimed to investigate mediator protein complex subunit 12 (MED12) exon 2 and telomerase reverse transcriptase (TERT) promoter mutations in a series of primary and recurrent fibroepithelial tumors. Sanger sequencing for MED12 exon 2 and TERT promoter was performed in 26 pairs of primary and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Mediator Complex

Share to Neoplasm Recurrence, Local

Share to Promoter Regions, Genetic

Share to Telomerase

Source

Identifiers

PMID: 34597441
DOI: 10.1111/pin.13172

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions.PMID 34597441Read ↗

Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adultsSemantic proximity Read ↗

Periductal Stromal Tumor of the Breast with a TERT Promoter Mutation: First Case Report with Comprehensive Molecular Analysis.Semantic proximity Read ↗

Stromal MED12 exon 2 mutations in complex fibroadenomas of the breast.Semantic proximity Read ↗

MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.Semantic proximity Read ↗

Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.Semantic proximity Read ↗

Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.Semantic proximity Read ↗

MED12, TERT and RARA in fibroepithelial tumours of the breast.Semantic proximity Read ↗

TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.Semantic proximity Read ↗

Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.Semantic proximity Read ↗

MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.Semantic proximity Read ↗

MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.Semantic proximity Read ↗

Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.